RBC Capital Markets came in at No. 5 on Dealogic’s 2024 M&A league tables (volume by adviser) while Barrenjoey ranked seventh. Big equity raises in the digital infrastructure sector were a major ...

In a report released yesterday, Daniel Perlin from RBC Capital maintained a Buy rating on Visa (V – Research Report), with a price target of ...

RBC Capital analyst Rishi Jaluria maintained a Buy rating on Coursera (COUR – Research Report) yesterday and set a price target of $10.00. The ...

In a report released yesterday, Daniel Perlin from RBC Capital maintained a Buy rating on Mastercard (MA – Research Report), with a price ...

RBC Capital analyst Ashish Sabadra maintained a Buy rating on MSCI (MSCI – Research Report) yesterday and set a price target of $675.00. The ...

Investing.com -- RBC Capital Markets has upgraded EssilorLuxottica (EPA:ESLX) to "outperform," citing strong fundamentals and growth opportunities in the ophthalmology sector. Shares of the ...

RBC Capital raised the firm’s price target on Visa (V) to $395 from $322 and keeps an Outperform rating on the shares after its Q4 earnings ...

$180,000 of RBC CAPITAL MARKETS LLC (FORMERLY REGISTERED AS ROYAL BANK OF CANADA) lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing. This included lobbying on ...

RBC Capital analyst Leonid Timashev maintained a Buy rating on Axsome Therapeutics (AXSM – Research Report) today and set a price target of ...

RBC Capital analyst Ashish Sabadra maintained a Hold rating on Clarivate (CLVT – Research Report) yesterday and set a price target of $6.00.

In a report released on January 29, Brad Erickson from RBC Capital maintained a Buy rating on Alphabet Class A (GOOGL – Research Report), with a price target of $235.00. The company’s shares ...

In a report released today, Nik Modi from RBC Capital maintained a Hold rating ... California-based The Clorox Co. manufactures and markets consumer and professional products.